Skip to main content
Clinical Trials/NL-OMON45897
NL-OMON45897
Withdrawn
Not Applicable

Deep Brain Stimulation of the Nucleus Basalis of Meynert in patients with Parkinson's Disease - NBM-DBS in PD

niversitair Medisch Centrum Groningen0 sites11 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson's
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
11
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient with GPi stimulation, with the NBM in reach of the electric field at least one DBS electrode
  • 2\. Patients should be able to give informed consent
  • 3\. patients should be on a stable medication regimen for at least 4 weeks

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study if any unstable internal disease is found.
  • Additional exclusion criteria is made to determine whether or not a subject can continue to the crossover trial. Subject with significant worsening of motor function during the screening trial, which is indicated by an increase of the UPDRS part III score more than 30%, will not continue to the crossover trial.

Outcomes

Primary Outcomes

Not specified

Similar Trials